The author said they had removed generative AI from RheumaNext v2, arguing that clinical tools needed transparent, reproducible logic rather than persuasive guesses. They reported that all 217 tests had passed and shared a 70-second demo.
The author wrote that AI’s first major healthcare benefit could be reducing documentation work rather than diagnosing patients. They described a workflow in RheumaNext v2, moving from Companion to Clinic Assistant, in which patients completed tailored intake forms and doctors clarified, reviewed and approved notes prepared for electronic health records. The author said this could reduce bureaucracy and give doctors more time for care.
The author, a rheumatologist, said they had built RheumaNext so patients’ accounts would not be lost between appointments. They wrote that symptoms and treatments could change, while a single visit captured only part of the picture. RheumaNext v2, they said, connected what patients reported with what clinicians needed to review.
Kolejny ważny krok dla RheumaNext! 🚀 NVIDIA zatwierdziła nasz dostęp do Inception Capital Connect. Przez najbliższe 3 miesiące RheumaNext będzie widoczne dla setek funduszy venture capital z ekosystemu NVIDIA. To jeszcze nie inwestycja - ale zdecydowanie otwarcie drzwi do https://t.co/L0qV6i7nQZ #RheumaNext #NVIDIA #VentureCapital #N/A
